SANTA ANA, Calif. & ROME–(BUSINESS WIRE)– Irvine Scientific, wereldleider in innovatie en productie van voedingsbodems van celculturen, reactanten en medische apparatuur voor industriële, klinische of wetenschappelijke toepassingen, heeft vandaag bekendgemaakt dat het BioCare Europe S.r.l. (BioCare) heeft overgenomen. Het in Rome gevestigde BioCare is een toonaangevende distributeur van voedingsbodems, medische apparatuur en instrumenten voor IVF.
Irvine Scientific voorziet de IVF-markt van cGMP, voedingsbodems voor celculturen met ongeëvenaarde prestaties en kwaliteit. Irvine Scientific ondersteunt IVF-klinieken over de hele wereld en werkt al enkele jaren aan een grotere aanwezigheid in Europa, waarbij het bedrijf zich vooral op het Verenigd Koninkrijk, Frankrijk en Duitsland richtte. BioCare is een toonaangevende distributeur van een brede keur aan IVF-producten en heeft een sterk commercieel netwerk opgezet in Europa, met de focus op Italië, Frankrijk, Griekenland, Portugal en Spanje.
Irvine Scientific Acquires Leading Distributor in European IVF Market BioCare Europe S.r.l.
SANTA ANA, Calif. & ROME–(BUSINESS WIRE)– Irvine Scientific, a world leader in the innovation and manufacture of cell culture media, reagents, and medical devices for industrial, clinical and research applications, today announced it has acquired BioCare Europe S.r.l. (BioCare). Based in Rome, Italy, BioCare is a leading distributor of in vitro fertilization (IVF) media, medical devices, and equipment.
Irvine Scientific provides the IVF market with cGMP cell culture media which is unrivalled in performance and quality. Supporting IVF hospitals and clinics worldwide, Irvine Scientific has been building a sales presence in Europe over the last several years, focused mainly in the UK, France, and Germany. BioCare is a leading distributor of a wide variety of IVF products to the European market and has built a strong sales network in Europe, focused mainly in Italy, France, Greece, Portugal and Spain.
The IVF market in Europe is the largest worldwide and is expected to grow stably. By leveraging the capabilities of BioCare and maximizing the synergy between the two companies Irvine Scientific will expand its presence in the European IVF market to take advantage of that growth.
“We are delighted to announce the acquisition of BioCare.” said Yuichi Nagano, President and CEO, Irvine Scientific. “With its well established network across the continent BioCare provides the connections and operations to enable us to better serve the European IVF market.”
Notes to Editors
About Irvine Scientific
Irvine Scientific, a member of JX Group, is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivalled service and quality to scientists working in cell therapy and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA and Tokyo, Japan. The company’s consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 40 years, Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services.
About BioCare Europe S.r.l.
BioCare Europe S.r.l. (BioCare) is a market leader in the field of assisted reproduction in Europe and distributes a wide range of media, high-end equipment and consumables for IVF centers. Collaborating directly with over two-third of the IVF centers in Europe – mainly in Italy, Spain, Greece, France and Switzerland – BioCare has developed an excellent relationship with reference centers and key opinion leaders. Ideal global partner of innovative IVF centers with utmost quality standards, BioCare also provides turnkey laboratories and ensures continuous assistance to IVF professionals.